Pressure Biosciences Inc (PBIO)

[namtae]

What happens during that year is what concerns me. Rape kits will be in R&D for the next year so a drain on capital.

The deal with ab sciex is another unknown because for some reason, there arent any specifics of the terms. Usually when an otc company makes a great deal, they cant wait to spell it out for the public. In PBIOs case, we get carrot dangling.

What about capital? The offering has been going on something like 7-8 months just to raise $5m? After paying off debt, commissions etc, theres very little left. How is PBIO going to financially handle the next 12 months burning cash and reporting losses? PBIO should address

The reverse split is always a concern although its mostly mitigated for PBIO if its part of an up list and sufficient capital raise at 50 cents or above. The 28 cent deal is taking forever so how much easier will it be at higher prices? Whats PBIOs share price with a reverse split and another financing around the corner?

So, although I can appreciate the vision longer term, these items above present risks I chose not to take. Not after PBIOs share price has more than doubled. i also wonder if this upward pressure in the stock will continue once the 28 cent financing is closed.

Considering the market valuation of PBIO is still relatively small, theres much upside if things work out. Also, PBIO is one of the few otc companies that are legit players trying to build real value. Again, its still a matter of risk/reward